Evaluation of Some Prognostic Factors in Acute Aluminum Phosphide Intoxicated Cases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

42 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-01

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

study of some laboratory and clinical findings which may show the severity of aluminium phosphide toxicity and the need of the cases to be admitted to ICU

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Paraffin Oil or Coconut Oil in Acute Aluminum Phosphide Poisoning

NCT04724655

Aluminum Phosphide Poisoning

COMPLETED EARLY_PHASE1

Alpha Lipoic Acid as an Adjuvant Treatment in Acute Phosphide Poisoning

NCT02760823

Toxicity

UNKNOWN PHASE2

Supportive Measures in Treatment of Aluminum Phosphide Poisoning

NCT03879356

Detection of Different Prognostic Factors and Their Relation With the Outcome Using New Protocol to Prove the Role of N-acetyl Cysteine and Adequate Supportive Measures in Aluminum Phosphide Poisoning

COMPLETED PHASE4

The Potential Therapeutic Role of Hydroxyethyl Starch and Hydrocortisone in Acute Aluminum Phosphide Poisoning

NCT04465539

Potential Therapeutic Role

COMPLETED NA

Serum Cholinesterase Level in Aluminum Phosphide Poisoning, the Possible Proposing Role of Atropin & Pralidoxime

NCT04192526

Toxicity;Chemical

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

aluminium phosphide poisoning is a major cause of death in intoxicated and suicidal cases since there is no antidote and there is no specific investigation for it so there is a need for further study to identify the cause of death and the most specific investigation in the case of AlP toxicity

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aluminum Phosphide Poisoning

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

survivors

some prognostic factors

Intervention Type DIAGNOSTIC_TEST

cortisol level, renin, troponin I, MDA ,catalase, super oxide dismutase, liver functions, kidney functions, arterial blood gases, sodium level, potassium level. white blood cells count

non survivors

some prognostic factors

Intervention Type DIAGNOSTIC_TEST

cortisol level, renin, troponin I, MDA ,catalase, super oxide dismutase, liver functions, kidney functions, arterial blood gases, sodium level, potassium level. white blood cells count

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

some prognostic factors

cortisol level, renin, troponin I, MDA ,catalase, super oxide dismutase, liver functions, kidney functions, arterial blood gases, sodium level, potassium level. white blood cells count

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. History of exposure or intake of Aluminum phosphide.
2. Clinical picture of Acute Aluminum phosphide poisoning including severe vomiting, hypotension, abdominal pain, cardio-pulmonary distress.
3. Cases of the age of 15 to 45 years old

Exclusion Criteria

\- 1. Cases with an unclear history. 2. History of co-morbidities or systemic diseases because of the possibility of misleading laboratory results.

3\. History of co-ingestion of drugs or another poison.

Minimum Eligible Age

15 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes